发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Ribociclib (Kisqali) for early breast cancer. Ribociclib （Kisqali）用于早期乳腺癌。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717f
{"title":"Ribociclib (Kisqali) for early breast cancer.","authors":"","doi":"10.58347/tml.2024.1717f","DOIUrl":"https://doi.org/10.58347/tml.2024.1717f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"e202-e203"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Femlyv - an orally disintegrating hormonal contraceptive. 简而言之：Femlyv——一种口服崩解激素避孕药。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717c
{"title":"In brief: Femlyv - an orally disintegrating hormonal contraceptive.","authors":"","doi":"10.58347/tml.2024.1717c","DOIUrl":"https://doi.org/10.58347/tml.2024.1717c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"200"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiviral drugs for seasonal influenza for 2024-2025. 2024-2025年季节性流感的抗病毒药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717a
{"title":"Antiviral drugs for seasonal influenza for 2024-2025.","authors":"","doi":"10.58347/tml.2024.1717a","DOIUrl":"https://doi.org/10.58347/tml.2024.1717a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"193-198"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison chart: Antiviral drugs for seasonal influenza for 2024-2025. 对比图：2024-2025年季节性流感抗病毒药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717d
{"title":"Comparison chart: Antiviral drugs for seasonal influenza for 2024-2025.","authors":"","doi":"10.58347/tml.2024.1717d","DOIUrl":"https://doi.org/10.58347/tml.2024.1717d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"e1-e5"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Marstacimab (Hympavzi) for hemophilia A and B. 马司他单抗（Hympavzi）用于血友病A和B。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717b
{"title":"Marstacimab (Hympavzi) for hemophilia A and B.","authors":"","doi":"10.58347/tml.2024.1717b","DOIUrl":"https://doi.org/10.58347/tml.2024.1717b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"198-199"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zolbetuximab (Vyloy) for gastric and gastroesophageal carcinoma. Zolbetuximab （Vyloy）治疗胃癌和胃食管癌。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717g
{"title":"Zolbetuximab (Vyloy) for gastric and gastroesophageal carcinoma.","authors":"","doi":"10.58347/tml.2024.1717g","DOIUrl":"https://doi.org/10.58347/tml.2024.1717g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"e204-e205"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isatuximab (Sarclisa) for multiple myeloma. Isatuximab （Sarclisa）治疗多发性骨髓瘤。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-12-09 DOI: 10.58347/tml.2024.1717e
{"title":"Isatuximab (Sarclisa) for multiple myeloma.","authors":"","doi":"10.58347/tml.2024.1717e","DOIUrl":"https://doi.org/10.58347/tml.2024.1717e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1717","pages":"e200-e201"},"PeriodicalIF":1.4,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inavolisib (Itovebi) for locally advanced or metastatic breast cancer. 治疗局部晚期或转移性乳腺癌的伊那韦利（Itovebi）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715f
{"title":"Inavolisib (Itovebi) for locally advanced or metastatic breast cancer.","authors":"","doi":"10.58347/tml.2024.1715f","DOIUrl":"https://doi.org/10.58347/tml.2024.1715f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"e186-e187"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axatilimab (Niktimvo) for chronic graft-versus-host disease. 阿沙替利单抗（Niktimvo）治疗慢性移植物抗宿主病。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715e
{"title":"Axatilimab (Niktimvo) for chronic graft-versus-host disease.","authors":"","doi":"10.58347/tml.2024.1715e","DOIUrl":"https://doi.org/10.58347/tml.2024.1715e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"e184-e185"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xanomeline/Trospium (Cobenfy) for schizophrenia. 治疗精神分裂症的 Xanomeline/Trospium (Cobenfy)。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715a
{"title":"Xanomeline/Trospium (Cobenfy) for schizophrenia.","authors":"","doi":"10.58347/tml.2024.1715a","DOIUrl":"https://doi.org/10.58347/tml.2024.1715a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"177-179"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信